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MODEL COMPARISON TESTS OF LINEAR FACTOR MODELS 
IN U.K. STOCK RETURNS 
ABSTRACT 
 This study uses the Bayesian approach of Barillas and Shanken(2018) and the classical 
approach of Barillas, Kan, Robotti and Shanken(2018) to conduct model comparison tests of 
nine linear factor models in U.K. stock returns.  The mean-variance efficiency of each factor 
model is rejected.  The Bayesian and classical approaches to model comparison can give 
different results.  Combining the evidence from the two approaches suggests that the six-factor 
model of Fama and French(2017) with small spread factors provides the best performance 
among the set of models considered.   
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I Introduction 
 Mean-variance efficiency of Markowitz(1952) plays a central role in testing asset 
pricing models such as the capital asset pricing model (CAPM) and arbitrage pricing theory 
(APT).  Different linear factor models specify different K factor portfolios to lie on the ex ante 
mean-variance frontier (Roll(1977), Grinblatt and Titman(1987))1.  In the presence of a risk-
free asset, testing mean-variance efficiency is equivalent to testing whether the maximum 
squared Sharpe(1966) performance of the K factors equals the maximum squared Sharpe 
performance of K factors and N test assets (Gibbons, Ross and Shanken(1989))2.  As well as 
providing a formal test of an asset pricing model, testing mean-variance efficiency also 
provides useful information to investors.  If the K factors lie on the ex ante mean-variance 
frontier, it tells us that we only need to invest in the K factors to maximize the mean-variance 
benefits from the investment opportunity set.  Likewise if the K factors do not lie on the mean-
variance frontier, then we can identify the optimal portfolio that is orthogonal to the K factors, 
which maximizes performance relative to the benchmark (Gibbons et al, MacKinlay(1995))3. 
 The classic test of mean-variance efficiency was developed by Gibbons et al (1989).  
This test has been widely used in a number of studies in U.S. stock returns such as Fama and 
French(1993,2015,2016,2017) and U.K. stock returns such as Fletcher(1994,2001), Gregory, 
                                                          
1 When factor models include economic factors, we can test the mean-variance efficiency of 
the model using mimicking portfolios for the economic factors. 
2 Ferson and Siegel(2009) extend the tests to examine the unconditional mean-variance 
efficiency of a model in the presence of conditioning information.   
3 Ferson and Siegel(2015) extend the optimal orthogonal portfolio analysis to the situation 
where investors wish to hold portfolios which lie on the unconditional mean-variance frontier 
in the presence of conditioning information. 
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Tharyan and Christidis(2013), and Michou and Zhou(2016) among others.  The Gibbons et al 
test usually rejects the mean-variance efficiency of different factor models that have been 
proposed in the literature.  As a result, a number of studies, such as 
French(2012,2015,2016,2017), compare alternative models by using metrics based on the 
pricing errors of the models to identify the model which is most reliable in practical 
applications. 
 A recent study by Barillas and Shanken(2017) shows that for conducting relative model 
comparison tests using a number of metrics such as the increase in Sharpe performance, 
statistical likelihoods, and the modified Hansen and Jagannathan(1997) distance measure (Kan 
and Robotti(2008)), the choice of test assets is irrelevant.  The only relevant comparison is how 
well each model prices the factors not included in the model.  Barillas and Shanken(2018) 
develop a Bayesian approach to test the mean-variance efficiency4 of a linear factor model and 
to conduct model comparison tests.  Their approach can be adapted whether the models are 
nested or non-nested to one another.  An alternative approach to compare models using 
classical statistics is developed by Barillas, Kan, Robotti and Shanken(2018).  Barillas et al 
compare models by their maximum squared Sharpe performance.  Barillas et al point out that 
the Bayesian and classical approaches can provide complementary insights about model 
performance. 
 I use the Bayesian and classical approaches of Barillas and Shanken(2018) and Barillas 
et al(2018) to conduct model comparison sets of nine linear factor models in U.K. stock returns.  
I also examine the mean-variance efficiency of each model using the Gibbons et al(1989) and 
Barillas and Shanken(2018) tests.  My sample period covers July 1983 and December 2016 
                                                          
44 Early Bayesian tests of mean-variance efficiency includes Shanken(1987), Harvey and 
Zhou(1990), and McCulloch and Rossi(1990,1991) among others 
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and I use two sets of test assets based on the excess returns of 16 size/book-to-market (BM) 
portfolios and 16 size/momentum portfolios.  My choice of models is motivated by the recent 
studies of Fama and French(2015,2016,2017), Asness, Frazzini, Israel and Moskowitz(2015), 
and Daniel Hirshleifer and Sun(2018). 
 There are four main findings in my study.  First, the mean-variance efficiency of each 
factor model is rejected using the size/momentum portfolios as the test assets.  With the 
size/BM portfolios, the Bayesian approach provides a more favourable picture of model 
performance.  Second, in the Bayesian pairwise model comparison tests, the six-factor Fama 
and French(2017) model with small spread factors performs the best.  The Daniel et al(2018) 
model also performs reasonably well.  Third, in the Bayesian multiple model comparison tests, 
the Daniel et al model is the clear winner.  Fourth, in the model comparison tests based on the 
squared Sharpe performance, the six-factor Fama and French(2017) provides the best relative 
performance and the Daniel et al model no longer significantly outperforms a number of 
models.  My study suggests that combining the evidence from both the Bayesian and classical 
model comparison tests, that the six-factor model of Fama and French(2017) with small spread 
factors is the most reliable model among the set of models I consider. 
 There are two main contributions from my study.  First, I complement the recent study 
by Barillas and Shanken(2018) by using the Bayesian approach to evaluate linear factor models 
in a different market.  I also complement the recent studies of Fama and 
French(2015,2016,2017) by examining the performance of their models in a different market.  
Recent studies by Hou, Xue and Zhang(2017) and Harvey(2017) highlight the importance of 
replication studies in Finance, which is common in other fields of science.  Second, I extend 
the prior evidence of the performance of the linear factor models in U.K. stock returns such as 
Fletcher(1994,2001), Gregory et al(2013), Davies, Fletcher and Marshall(2015), and Michou 
and Zhou(2016) among others.  I extend these studies by using the Bayesian and classical 
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approaches to conduct model comparison tests using the time-series regression approach rather 
the using the cross-sectional R2 metric in Davies et al. 
 My paper is organized as follows.  Section II describes the research method.  Section 
III discusses the data used in my study.  Section IV reports the empirical results and final 
section concludes.  
II Research Method 
 Linear factor models such as the CAPM and APT predict: 
                 E(ri) = Σk=1Kβikrk                                                            (1) 
where ri is the excess return on asset i, rk is the factor risk premium on the kth factor, βik is the 
beta on asset i relative to factor k, for k = 1,…,K, and K is the number of factors in the model.  
The prediction in equation (1) can be evaluated from the time-series regression: 
     rit = αi + Σk=1Kβikrkt + uit for i=1,…..N                                             (2) 
where rit is the excess return on asset i at time t, rkt is the excess return on factor k at time t, uit 
is a random error term on asset i at time t with E(uit) = 0 and E(uitrkt) = 0 for each kth factor, 
and N is the number of test assets.  The beta model in equation (1) imposes testable restrictions 
in equation (2) as: 
                     H0: αi = 0, for i=1,…..,N                                                       (3) 
where αi is the alpha of asset i. 
 Gibbons et al(1989) derive a multivariate F test of the null hypothesis of equation (3).  
Assuming the residuals from equation (2) have a multivariate normal distribution with zero 
mean and constant covariance matrix, the test statistic is given by: 
               GRS = [(T-N-K)/N]*(α’Σ-1α)/(1+θK2)                                              (4) 
where α is a (N,1) vector of αi’s from equation (2), Σ is the Maximum Likelihood (ML) estimate 
of the (N,N) residual covariance matrix from equation (2), θK2 is the maximum squared 
Sharpe(1966) performance of the K factors in the linear factor model, and T is the number of 
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observations.  The θK2 term is estimated as uK’VK-1uK, where uK is a (K,1) vector of average 
excess returns on the K factors, and VK is the (K,K) factor covariance matrix.  Gibbons et 
al(1989) show that the quadratic form α’Σ-1α can be written as: 
                             α’Σ-1α = θ2N+K – θ2K                                                                        (5) 
where θ2N+K is the maximum squared Sharpe performance of the N+K assets and is given by 
uN+K’V-1N+KuN+K, where uN+K is a (N+K,1) vector of average excess returns, and VN+K is the 
(N+K,N+K) covariance matrix.  If some combination of the K factor portfolios lies on the 
mean-variance frontier of the N+K assets, then θ2N+K = θ2K.  Under the null hypothesis that 
there is a portfolio of the K factors that lies on the ex ante mean-variance frontier of the N+K 
assets, the GRS test has a central F distribution with N and T-N-K degrees of freedom.   
 Bayesian tests of equation (3) have been developed by Shanken(1987), Harvey and 
Zhou(1990), and McCulloch and Ross(1990,1991) among others.  Barillas and Shanken(2018) 
build on these earlier studies and propose a new Bayesian test of αi = 0, which can be solved 
analytically.  Barillas and Shanken assume a diffuse prior for the factor betas and residual 
covariance matrix and an informative prior for α under the alternative hypothesis as 
MVN(0,kΣ), where MVN is the multivariate normal distribution.  The k term reflects the 
researcher’s view of the likely magnitude of the expected excess return deviations of the model.  
The informative prior for α links model mispricing with the residual covariance matrix, which 
makes very high Sharpe ratios unlikely (Grinblatt and Titman(1983), MacKinlay(1995), and 
Pastor and Stambaugh(2000)).  Barillas and Shanken show that k is given by k = (θ2N+K – 
θ2K)/N, where the researcher specifies the value of θ2N+K5.                                
                                                          
5 Imposing an upper bound on θ2N+K has been used in different applications such as Cochrane 
and Saa-Requejo(2000), Chretien and Kammoun(2017), and Huang and Zhou(2017).  
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 Proposition 1 in Barillas and Shanken(2018) shows that the Bayes factor (BF) of the 
mean-variance efficiency test is given by: 
                BF = (1/Q)*(|S|/|SR|)
(T-K)/2                                            (6) 
where S is the (N,N) cross-product matrix of the residuals from equation (2), SR is the (N,N) 
cross-product matrix of the residuals from equation (2) when the N αi’s are constrained to be 
zero, and the Q6 term is given by equation (11) in Barillas and Shanken.  The posterior 
probability of the null hypothesis of mean-variance efficiency is given by BF/(1+BF).  I refer 
to the Bayesian test as the B-GRS test.  I estimate the B-GRS test of mean-variance efficiency 
by setting θ2N+K as equal to multiples of 1.2, 1.4, 1.6, 1.8, and 2 to maximum squared Sharpe 
performance of the factors in the model as in Barillas and Shanken. 
 The GRS and B-GRS examine the absolute fit of a model.  Given that most models are 
rejected, researchers will often focus on relative model comparison tests to examine which 
factor models are more reliable in practical applications.  Studies often compare models using 
metrics of the pricing errors of the N test assets (Fama and French(2012,2015,2016,2017)), 
such as the mean absolute alpha.  Better models have lower mispricing.  Barillas and 
Shanken(2017) show that for relative model comparison tests, the choice of the test assets is 
irrelevant for a number of metrics.  Barillas and Shanken show that the only relevant 
comparison is how well the model prices the factors not included in the model. 
Barillas and Shanken(2018) develop a Bayesian approach for model comparison tests.  
This approach can be used to conduct both pairwise model and multiple model comparison 
                                                          
6 The Q statistic was initially derived by Harvey and Zhou(1990) who solved it using Monte 
Carlo integration.  Barillas and Shanken(2018) derive the analytical expression for the Q 
statistic. 
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tests.  Barillas and Shanken assume that all models include the market portfolio7.  The market 
portfolio plays a central role in the CAPM and the Intertemporal CAPM (ICAPM) and is the 
aggregate supply of securities (Barillas and Shanken and Fama and French(2017)).  In addition, 
Harvey and Liu(2018) find that the market index is the most important factor in reducing the 
mispricing in individual stocks in U.S. stock returns.   
Barillas and Shanken(2018) develop the model comparison tests based on the marginal 
likelihood (ML) of each model.  Proposition 3 of Barillas and Shanken shows that the ML of 
each model can be computed as:  
                       ML = MLU(f|mkt)*MLR(f
*|mkt,f)*MLR(r|mkt,f,f
*)                                    (7) 
where MLU(f|mkt) is the unrestricted ML from the regression of the non-market factors (f) 
included in a model on the market index (mkt), MLR(f
*|mkt,f) is the restricted (where alphas 
are set equal to zero) ML from the regression of the excluded factors (f*) on the mkt and f 
factors, and MLR(r|mkt,f,f
*) is the restricted ML from the regression of the test assets on all the 
factors included in all models. Since the MLR(r|mkt,f,f
*) term is common across all models, 
this term drops out when calculating the ML of each model.  Assuming that each model has an 
equal prior probability (Barillas and Shanken), the posterior probability of each model i is given 
as MLi = MLi/Σj=1MMLj, where M is the number of models being compared.  To implement the 
Bayesian model comparison tests, a prior needs to be specified for the maximum Sharpe 
performance relative to the market index.  I follow Barillas and Shanken and use the maximum 
Sharpe performance as multiples of 1.25, 1.5, 2, and 3 of the Sharpe ratio the market index. 
 The second approach I use to compare models is based on Barillas et al(2018) that 
compares models directly on the basis of their maximum squared Sharpe performance.  Barillas 
                                                          
7 Barillas and Shanken(2018) extend their approach to allow no one factor to be automatically 
included in all models. 
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et al develop the relevant tests and asymptotic distribution theory for both pairwise model 
comparison tests and multiple model comparison tests of the equality of squared Sharpe 
performance measures between models.  An important issue is that the exact form of the test 
depends upon whether the models are nested to one another or non-nested both for the pairwise 
and multiple model comparison tests8. 
For pairwise model comparison tests in the case of nested models, where one model is 
a subset of another model, the GRS test can be used to examine the null hypothesis of zero 
alphas of the excluded factors relative to the smaller factor model.  For non-nested models, 
Proposition 1 of Barillas et al provides the relevant test, which has an asymptotic normal 
distribution.  An issue that arises in non-nested model comparison tests is when the models 
include overlapping factors.  Models can have equal squared Sharpe performance when the 
tangency portfolios in each model is spanned by the overlapping factors in each model.  Barillas 
et al suggest a sequential approach in this case.  First, the GRS test can be used to test the null 
hypothesis of zero alphas of the additional factors in each model on the overlapping factors 
from each model.  Second, if the spanning hypothesis is rejected the normal test from 
Proposition 1 can be used.  I follow the sequential approach in this study using a significance 
level of 5%. 
For multiple model comparison tests in the case of nested models, Barillas et al(2018) 
show that the pairwise nested model comparison tests can be adapted in this case.  The 
alternative model includes all the factors contained in the nested models.  For non-nested model 
                                                          
8 Barillas et al(2018) point out that their model comparison tests require at least one model to 
have a non-zero Sharpe performance.  I am able to reject the null hypothesis that θ2K = 0 for 
every factor model included in this study. 
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comparison tests, each model is taken as the benchmark model and the null hypothesis is tested 
that the benchmark model performs as well as the alternative (r) models in terms of maximum 
squared Sharpe performance.  The null hypothesis is an inequality and so Barillas et al use the 
Likelihood Ratio (LR) test on Wolak(1987,1989) building on the earlier results of Kan, Robotti 
and Shanken(2013) (see also Gospodinov, Kan and Robotti(2013)).  
III Data 
A) Test Assets 
 I use two groups of test assets, similar to Fama and French(2012), to examine the mean-
variance efficiency of linear factor models in U.K. stock returns between July 1983 and 
December 2016.  The first group is 16 portfolios of stocks sorted by size and book-to-market 
(BM) ratio.  The second group is 16 portfolios of stocks sorted by size and momentum.  The 
portfolios are value weighted buy and hold monthly returns.  The portfolios include all U.K. 
stocks traded on the London Stock Exchange and smaller investment markets, which meet the 
criteria for inclusion.  The stock return and market values come from the London Share Price 
Database (LSPD) provided by the London Business School, and book values come from 
Worldscope.  I compute excess returns using the one-month U.K. Treasury Bill return from 
LSPD and Datastream.  Full details on the construction of the test assets is available on request.  
Table 1 reports the average monthly excess returns of the size/BM portfolios (panel A) and 
size/momentum portfolios (panel B).   
The average excess returns of the size/BM portfolios in panel A of Table 1 range 
between -0.064% (Small/Growth) and 0.681% (3/Value).  The value effect is present across all 
size quartiles, where the Value portfolio has a higher average excess return than the Growth 
portfolio.  The value effect is strongest in the smaller companies.  The size effect varies across 
BM quartiles.  It is only for the Value portfolios that the Small portfolio has a higher average 
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excess return than the Big portfolio.  For the growth portfolios, the Big portfolio has a higher 
average excess return than the Small portfolio. 
 The size/momentum portfolios in panel B of Table 1 have a larger spread in average 
excess returns than the size/BM portfolios.  The average excess returns range between -0.437% 
(2/Losers) and 1.380% (Small/Winners).  There is a strong momentum effect as the Winners 
portfolio has a higher average excess return than the Losers portfolio across all size groups.  
The momentum effect is strongest in smaller companies.  Compared to the size/BM portfolios, 
there is a stronger size effect in the size/momentum portfolios.  Excluding the Losers portfolios, 
the Small portfolio has a higher mean excess return than the Big portfolio.  The size effect is 
strongest in the Winners portfolios.   
B) Factor Models 
I focus on nine linear factor models in my study.  Details of the construction of the 
factor models are available on request.  The models include: 
1. CAPM 
This model is a single-factor model that uses the excess returns of the U.K. stock market 
index (Mkt) as the proxy for aggregate wealth. 
2. Fama and French(1993) (FF) 
 The FF model is a three-factor model.  The factors are the excess return on the market 
index and two zero-cost portfolios that capture the size (SMB) and value/growth (HML) effects 
in stock returns.   
3. Carhart(1997) 
The Carhart model is a four-factor model.  The factors are the three factors in the FF 
model and a zero-cost portfolio that captures the momentum effect (WML) in stock returns.   
4. Fama and French(2015a) FF5 
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 This model is a five-factor model.  The factors include the factors in the FF model and 
two zero-cost portfolios that capture the profitability (RMW) and investment growth (CMA) 
effects in stock returns.  I refer to the SMB, HML, RMW, and CMA factors as combined spread 
factors using the notation of Fama and French(2017).  The SMB factor constructed using the 
FF5 model is used across all models. 
5. Fama and French(2017) (FF5s) 
This model is a five-factor model.  The factors are the market index, SMB, and the 
small ends of the combined spread factors of HML (HMLS), RMW (RMWS), and CMA 
(CMAS). 
6. Fama and French(2017) (FF6) 
This model is a six-factor model, which augments the FF5 model with the combined 
spread momentum (WML) factor. 
7. Fama and French(2017) (FF6s) 
This model is a six-factor model, which augments the FF5s model with the small end 
of the combined spread WML factor (WMLS). 
8. Daniel et al(2018) (DHS) 
 This model is a three-factor model, which includes the excess market returns and two 
zero-cost portfolios that capture financing (FIN) and post-earnings announcement drift (PEAD) 
effects in stock returns.  Daniel et al(2018) motivate their model as a behavioural factor model. 
9. Asness et al(2015) (AFIM) 
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 This model is a six-factor model, which replaces the HML factor in the FF6 model with 
a more timely version (HMLT) of the value factor as in Asness and Frazzini(2013)
9. 
Table 2 reports summary statistics of the factor excess returns between July 1983 and 
December 2016.  The summary statistics include the mean and standard deviation of monthly 
factor excess returns (%).  The final column reports the t-statistic of the null hypothesis that 
the average excess returns on the factors equal zero. 
 
Table 2 here 
 
 Table 2 shows that a number of the factors have significant positive average excess 
returns.  The WMLS factor has the highest mean excess return at 1.218%, followed by the 
WML factor.  This result confirms the strong momentum effect in U.K. stock returns, and the 
fact that momentum is stronger in smaller companies.  The HML factor has a significant 
positive average excess return as does the HMLS factor.  The higher average excess return on 
the HMLS factor confirms that the value effect is stronger in small companies.  These patterns 
between the WML and WMLS factors and the HML and HMLS factors are consistent with 
Fama and French(2017) in U.S. stock returns.  In contrast, the more timely version of the value 
(HMLT) factor has a lower average excess return than the HML factor and is statistically 
insignificant. 
 The SMB factor in Table 2 has a tiny average excess return.  There is no significant 
profitability effect using the RMW factor.  The average excess return on the RMW factor is 
                                                          
9 Barillas et al(2018) find that using the more timely version of the HML factor in the Fama 
and French(2017) six-factor model performs well in model comparison tests using U.S. stock 
returns. 
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the second lowest across all factors.  The average excess returns on the RMWS factor is 
significant at the 10% level.  There is a strong investment effect, with significant mean excess 
returns on the CMA and CMAS factors.  The two behavioural factors of Daniel et al(2018) also 
have significant mean excess returns.  It is only for the CMA, WML, WMLS, CMAS and FIN 
factors that the t-statistics are larger than the critical t-value recommended by Harvey, Liu and 
Zhu(2016)10.  
IV Empirical Results 
 I begin my empirical tests by examining the mean-variance efficiency, using both the 
GRS test and the B-GRS test, for each of the nine linear factor models using both sets of test 
assets.  Using the size/momentum portfolios as the test assets, both the GRS and B-GRS tests 
strongly reject the mean-variance efficiency of each factor model and so I only report the GRS 
and B-GRS tests for the size/BM portfolios.  Table 3 reports the mean-variance efficiency tests 
using the size/BM portfolios (panel A) and summary metrics of performance based on the 
alpha11 in panels B (size/BM) and C (size/momentum) portfolios.  The summary metrics 
include the mean absolute value of alpha (A|αi|), the mean absolute value of alpha divided by 
the mean absolute value of average excess return deviation from the market index (A|αi|/A|ri|), 
and the ratio of the mean squared standard error of alpha and the mean squared alpha 
(As2(αi)/Aαi2).   
 
Table 3 here 
                                                          
10 Harvey et al(2016) find that prior empirical research have found 316 variables that are known 
to be related to stock returns.  To control for multiple testing issues, Harvey et al recommend 
the use of higher critical values of the t-statistic to judge statistical significance. 
11 See Fama and French(2015,2016,2017).   
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 Panel A of Table 3 suggests that the rejection of mean-variance efficiency depends 
upon whether we use the GRS test or the B-GRS test.  Using the GRS test, it is only the CAPM, 
FF, and DHS models that can be rejected at the 5% significance level.  In contrast for the B-
GRS test, there is little evidence against the mean-variance efficiency of the factor models.  
The exception to this result is for the DHS model, where the posterior probability is 0.039 when 
the prior maximum Sharpe ratio is 1.2.  This difference in results between the GRS and B-GRS 
tests could be driven by the fact that under the alternative hypothesis the alphas in the GRS test 
are unbounded but are bounded in the GRS test. 
 Using the pricing error metrics to compare models, panel B of Table 3 shows that, the 
FF6 model has the best performance using the size/BM portfolios.  The Carhart, FF5, FF5s, 
FF6s, and AFIM models all have similar performance using the A|αi| and A|αi|/A|ri| measures.  
Even although the mean-variance efficiency of these models cannot be rejected, each model 
still leaves a substantial proportion of the average excess returns unexplained.  The minimum 
value of the A|αi|/A|ri| measure is 59.9%.  Much of the variation in αi’s is due to sampling error.  
The poorest performing model is the DHS model, where all three pricing error metrics are 
noticeably poorer than the other models. 
 Using the size/momentum portfolios in panel C of Table 3, shows that the models that 
include a momentum factor, Carhart, FF6, FF6s, and AFIM models have the best performance 
using the A|αi| and A|αi|/A|ri| measures.  The FF6s model is the best performing model among 
the models using these two metrics.  The DHS model has again the poorest performance with 
the A|αi| and A|αi|/A|ri| measures.  All of the models have low As2(αi)/Aαi2 measures, which 
suggests that the sampling error only explains a small proportion of the spread in alphas. 
 The mean-variance efficiency results show that the mean-variance efficiency of each 
factor model is rejected when using the size/momentum portfolios.  The rejection of the mean-
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variance efficiency of the factor models is similar to Fletcher(1994,2001) and Gregory et 
al(2013) in U.K. stock returns and Fama and French(2015,2016) in U.S. stock returns.  Across 
the two sets of test assets, the pricing error metrics suggest that the best performing model is 
the FF6s model and the poorest performing model is the DHS model.  The superior relative 
performance of the FF6s model is consistent with Fama and French(2017).  The DHS model is 
at a disadvantage compared to the alternative multifactor models as the factors in these models 
are all formed using the same stock characteristics as used in forming the test assets. 
 I next use the Bayesian approach to conduct pairwise model comparison tests and 
multiple model comparison tests between all nine factor models.  The Bayesian pairwise model 
comparison tests are reported in Table 4 and the multiple model comparison tests are included 
in Table 5.  The tables report the posterior probability of each model.  The posterior 
probabilities in Table 4 are for the models in the rows and the corresponding probabilities for 
the models in the columns are one minus the posterior probabilities. 
 
Table 4 here 
Table 5 here 
  
Table 4 shows that the CAPM and FF models perform poorly relative to the alternative 
multifactor models, with a posterior probability close to zero.  This result holds across all prior 
maximum Sharpe ratio multiples.  The superior performance of the FF5 model relative to the 
FF model confirms the results in Fama and French(2015,2016).  The Carhart model performs 
poorly relative to the alternative five-factor models, six-factor models, and the DHS model.  
The superior performance of the six-factor models relative to the Carhart model highlights the 
benefits of including the profitability and investment factors in the factor model.  The poor 
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relative performance of the Carhart model stands in sharp contrast to the pricing error metrics, 
where it is one of the best models.   
 Among the two five-factor models, the FF5 model has a considerable higher posterior 
probability than the FF5s model, suggesting better relative performance.  This result differs 
from Fama and French(2017).  At the higher prior maximum Sharpe ratio multiples of 2 and 3, 
both the FF5 and FF5s models significantly underperform the six-factor models.  This result 
highlights the importance of the momentum factor.  The DHS model also significantly 
outperforms the FF5 and FF5s models across all prior Sharpe ratio multiples. 
 Among the six-factor models, the FF6 model significantly underperforms the FF6s and 
AFIM models at the prior maximum Sharpe ratio multiples of 2 and 3.  The good relative 
performance of the AFIM model, which uses the more timely HML factor, is consistent with 
Barillas et al(2018).  The FF6s model significantly outperforms the AFIM model at the prior 
maximum Sharpe ratio multiples of 2 and 3.  The DHS model significantly outperforms the 
FF6 model at prior Sharpe ratio multiples of 1.25 and 1.5.  The DHS model performs less well 
relative to the FF6s model and significantly underperforms the FF6s model at prior maximum 
Sharpe ratio multiples of 1.5 and above. 
 Table 4 suggests that the FF6s model has the best performance in the Bayesian pairwise 
model comparison tests.  This finding is consistent with the pricing error metrics of the test 
assets.  The AFIM and DHS models also perform well relative to the alternative models.  The 
performance of the DHS model is in complete contrast to the pricing error metrics in Table 3, 
where it is the poorest performing model.  Likewise the Carhart model performs well in the 
pricing error metrics but poorly in the model comparison tests.  These results are consistent 
with Barillas and Shanken(2017) and highlights the importance of taking account of the pricing 
of excluded factors in the alternative models in model comparison tests. 
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 The model comparison tests in Table 4 are based on pairwise model comparison tests.  
Table 5 shows that when conducting multiple model comparison tests, that the FF6s and AFIM 
models have a posterior probability close to zero.  This result holds across all prior maximum 
Sharpe ratio multiples.  This finding suggests that when conducting relative model comparison 
tests, it is important to take account of the excluded factors in all of the alternative models.  The 
DHS model is the clear winner in Table 5.  The posterior probability of the DHS model exceeds 
0.98 when the prior maximum Sharpe ratio is 1.5 and above.  This result is striking when 
considering the poor performance of the DHS model in the pricing error metric of the test assets 
in Table 3.  It again highlights, as in Barillas and Shanken(2017), the importance of taking 
account of excluded factors when comparing factor models. 
 I repeat the model comparison tests but this time evaluate the models by the maximum 
squared Sharpe performance of Barillas et al(2018).  Table 6 reports the pairwise (panels A 
and B) model comparison tests, and panel C reports the multiple model comparison tests using 
the maximum squared Sharpe performance.  Panel A presents the difference in the bias-
adjusted maximum squared Sharpe performance (ShpDiff)12 between every pair of models and 
panel B are the corresponding p values of the equality of the squared Sharpe performance 
between every pair of models.  Where the ShpDiff measure is negative (positive), the squared 
Sharpe performance of the model in the row is lower (higher) than the model in the column.  
Panel C includes the LR test of Wolak(1987,1989) of the multiple non-nested model 
                                                          
12 It is well known that the sample ML estimate of θ2K has an upward bias (Ferson and 
Siegel(2003)).  The bias-adjusted squared Sharpe performance is given by multiplying the ML 
estimate of θ2K by (T-K-2)/T and subtracting K/T (see Barillas et al(2018)). 
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comparison tests and corresponding p value (pnon-nested)
13.  The r column is the number of 
alternative non-nested models, and θ2K is the bias-adjusted squared Sharpe performance of each 
model.  The final column includes the p value of the multiple nested model comparison tests.  
The test statistics are corrected for heteroscedasticity.   
 
Table 6 here 
 
 Panels A and B of Table 6 show that as with the Bayesian model comparison tests, the 
CAPM and FF models perform poorly relative to the alternative multifactor models.  Both 
models provide a significant lower squared Sharpe performance than all the alternative models 
and are strongly rejected in the multiple model comparison tests.  The Carhart model performs 
better in Table 6 compared to the Bayesian tests and yields a similar maximum squared Sharpe 
performance to the FF5, FF5s, and DHS models.  However the Carhart model significantly 
underperforms the three six-factor models and is strongly rejected in the multiple model 
comparison tests.  In contrast to the Bayesian tests, the FF5 and FF5s model yield a similar 
squared Sharpe performance, which is more consistent with Fama and French(2017).  Likewise 
both models yield a similar squared Sharpe performance to the DHS model.  However both the 
FF5 and FF5s models significantly underperform the FF6s and AFIM models.  Both models 
are likewise rejected in the multiple model comparison tests. 
 Among the three six-factor models, the FF6 model provides a significant lower squared 
Sharpe performance than the FF6s and AFIM models.  The FF6 model is also rejected in the 
multiple model comparison tests.  The FF6s model has a significant higher squared Sharpe 
                                                          
13 Using a bootstrap approach to estimate the p values of the LR test are similar to those reported 
in Table 6. 
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performance than the AFIM model at the 10% significance level.  The FF6s model also 
provides a significant higher squared Sharpe measure than the DHS model.  However in the 
multiple non-nested model comparison tests using either the FF6s or AFIM models as the 
benchmark, we cannot reject the null hypothesis that each model performs as well as the 
alternative models in terms of squared Sharpe performance.  In contrast to the Bayesian 
multiple model comparison tests, the DHS model no longer delivers superior performance as 
we can reject the null hypothesis that the DHS model performs as well as the alternative non-
nested models.   
 The model comparison tests in Table 6 provide an alternative perspective on relative 
model performance to the Bayesian tests in Tables 4 and 5.  The FF6s model performs well 
using both approaches.  In contrast the DHS model performs well in the Bayesian tests but not 
in the classical tests due to the smaller bias-adjusted maximum squared Sharpe performance.  
The Bayesian approach focuses on the marginal likelihood of the model given the underlying 
prior belief of the alphas, whereas the classical test focuses directly on the maximum squared 
Sharpe performance.  Combining the evidence from both model comparison approaches, would 
suggest that the FF6s model has the best relative performance among the set of models 
considered. 
V Conclusion 
 This paper uses the Bayesian and classical approaches of Barillas and Shanken(2018) 
and Barillas et al(2018) to conduct model comparison tests of nine linear factor models in U.K. 
stock returns.  The study likewise tests the mean-variance efficiency of each model using the 
classical Gibbons et al(1989) test and the Bayesian approach of Barillas and Shanken.   There 
are four main findings from my study.   
First, the mean-variance efficiency of each factor model is rejected using the 
size/momentum portfolios.  This result holds for both the GRS and B-GRS test statistics.  Using 
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the size/BM portfolios as the test assets, the B-GRS test provides a more favourable picture of 
model performance than the GRS test.  The rejection of the mean-variance efficiency of the 
linear factor models in U.K. stock returns is consistent with earlier studies such as 
Fletcher(1994,2001), Gregory et al(2013) among others and in U.S. stock returns as Fama and 
French(2015,2016). Using the pricing error metrics of the test assets to compare models, the 
FF6s model has the best performance.  Most of the factor models perform reasonably well in 
the size/BM portfolios.  Models that include the momentum factor (Carhart, FF6, FF6s, and 
AFIM) have the best performance in the size/momentum portfolios.  The DHS model has the 
poorest performance using the pricing error metrics of the test assets.  The DHS model is at an 
inherent disadvantage to the alternative multifactor models as they are formed using the same 
set of stock characteristics involved in forming the test assets. 
 Second, in the Bayesian pairwise model comparison tests the FF6s model has the best 
performance.  The AFIM and DHS models also perform well.  The striking result is that some 
of the best performing models in the pricing error metrics of the test assets such as the Carhart 
model perform poorly in the pairwise model comparison tests but the converse is true of the 
DHS model.  This finding is consistent with Barillas and Shanken(2017) that evaluating models 
by pricing error metrics of the test assets can give different results to looking at the pricing of 
excluded factors. 
 Third, in the Bayesian multiple model comparison tests, the DHS model is the clear 
winner.  The posterior probability of the DHS model is at least 0.985 when the prior maximum 
Sharpe ratio multiple is 1.5 and above.  Again this is a striking result compared to the pricing 
error metrics of the test assets.  The FF6s and AFIM models which perform well in the pairwise 
model comparison tests have a posterior probability of zero.  This finding suggests that it is 
important to evaluate models taking account of the factors in all the alternative models. 
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 Fourth, using the classical model comparison tests of Barillas et al(2018) shows that 
the FF6s and AFIM models have the best performance using the maximum squared Sharpe 
performance.  The FF6s model is able to significantly outperform all the alternative factor 
models at the 10% significance level.  In contrast, the DHS model performs less well and is 
only able to significantly outperform the CAPM and FF models.  This finding suggests that the 
Bayesian and classical approaches to model comparison can give different results and each 
approach evaluates the models from a different perspective. 
 My study suggests that looking at the combined evidence in the Bayesian and classical 
model comparison tests that the six-factor Fama and French(2017) factor model with small 
spread factor models provides the best relative performance in U.K. stock returns among the 
set of models considered here.  My study has focused on specific factor models and could be 
extended by searching for the best combination of factors as in Barillas and Shanken(2018).  
Likewise the study could address alternative factor models such as Hou, Xue and Zhang(2015), 
Stambaugh and Yuan(2017), and Grinblatt and Saxena(2017).  I leave an examination of these 
issues to future research.  
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Table 1 Summary Statistics of Test Assets 
Panel A: 
Size/BM Growth  2 3 Value 
Small -0.064 0.304 0.466 0.650 
2 -0.024 0.457 0.562 0.600 
3 0.286 0.417 0.531 0.681 
Big 0.343 0.434 0.477 0.576 
Panel B: 
Size/Momentum Losers 2 3 Winners 
Small -0.244 0.598 0.807 1.380 
2 -0.437 0.271 0.537 1.277 
3 -0.111 0.514 0.686 1.011 
Big 0.049 0.429 0.674 0.633 
 
The table includes the average monthly excess returns (%) of 16 size/BM portfolios (Panel A) 
and 16 size/momentum portfolios (Panel B) between July 1983 and December 2016.  The 
size/BM portfolios are sorted from Small to Big stocks in the rows and from Growth to Value 
stocks in the columns.  The size/momentum portfolios are sorted from Small to Big in the rows 
and from Losers to Winners in the columns.  
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Table 2 Summary Statistics of Factors 
Factor Mean Standard Deviation t-statistic 
Market 0.434 4.185 2.071 
SMB 0.015 2.945 0.10 
HML 0.300 2.552 2.351 
RMW 0.145 2.018 1.44 
CMA 0.411 1.896 4.341 
WML 0.907 3.789 4.801 
HMLS 0.391 3.039 2.58
1 
RMWS 0.210 2.278 1.85
2 
CMAS 0.482 2.002 4.83
1 
WMLS 1.218 3.664 6.66
1 
FIN 0.426 1.755 4.871 
PEAD 0.254 2.224 2.281 
HMLT 0.202 3.209 1.26 
 
1 Significant at 5% 
2 Significant at 10% 
 
The table reports summary statistics of the excess returns of the factors in the linear factor 
models between July 1983 and December 2016.  The summary statistics include the mean and 
standard deviation of the monthly excess returns (%).  The t-statistic examines the null 
hypothesis that the average excess returns of the factors equal zero.  The Market, SMB, HML, 
WML, RMW, and CMA factors are the excess returns on the U.K. market index, and zero-cost 
portfolios of the size (SMB), value/growth (HML), momentum (WML), profitability (RMW), 
and investment growth (CMA) effects in U.K. stock returns.  The HMLS, WMLS, RMWS, and 
CMAS are the small ends of the HML, WML, RMW, and CMA spread factors.  The FIN and 
PEAD factors are the two behavioural factors in the Daniel et al(2018) model.  The HMLT 
factor is the more timely version of the HML factor of Asness and Frazzini(2013).  
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Table 3 Tests of Mean-Variance Efficiency of Factor Models 
 
Panel A GRS p value 1.2 1.4 1.6 1.8 2 
CAPM 1.917 0.017 0.337 0.228 0.165 0.133 0.120 
FF 1.671 0.049 0.303 0.237 0.241 0.294 0.391 
Carhart 1.342 0.168 0.598 0.915 0.987 0.998 0.999 
FF5 1.090 0.362 0.760 0.961 0.994 0.999 0.999 
FF5s 1.407 0.134 0.509 0.857 0.975 0.995 0.999 
FF6 1.039 0.413 0.923 0.995 0.999 0.999 0.999 
FF6s 1.250 0.226 0.927 0.997 0.999 0.999 0.999 
DHS 2.228 0.004 0.039 0.088 0.295 0.661 0.896 
AFIM 1.485 0.101 0.662 0.967 0.997 0.999 0.999 
Panel B: 
Size/BM A|αi| A|αi|/A|ri| As2(αi)/Aαi2    
CAPM 0.158 1.038 0.641     
FF 0.112 0.737 0.450     
Carhart 0.105 0.689 0.540     
FF5 0.097 0.642 0.823     
FF5s 0.102 0.671 0.679     
FF6 0.091 0.599 0.883     
FF6s 0.098 0.649 0.864     
DHS 0.316 2.075 0.191     
AFIM 0.102 0.671 0.882     
Panel C: 
Size/Momentum A|αi| A|αi|/A|ri| As2(αi)/Aαi2    
CAPM 0.441 1.098 0.094     
FF 0.455 1.133 0.044     
Carhart 0.258 0.644 0.100     
FF5 0.431 1.073 0.052     
FF5s 0.463 1.154 0.047     
FF6 0.254 0.634 0.101     
FF6s 0.200 0.499 0.163     
DHS 0.461 1.148 0.074     
AFIM 0.252 0.629 0.099     
 
The table reports the GRS test and B-GRS test of mean-variance efficiency  and summary 
metrics of model performance of nine linear factor models between July 1983 and December 
2016.  Panel A includes the GRS test and corresponding p value (p(GRS)), and the posterior 
probabilities from the B-GRS test using the size/BM portfolios as the test assets.  The prior 
maximum Sharpe performance is set equal to multiples of 1.2, 1.4, 1.6, 1.8, and 2 the maximum 
Sharpe performance of the factors in the model.  Panels B and C report the summary metrics 
of pricing performance using the size/BM portfolios (panel B) and size/momentum portfolios 
(panel C) as the test assets.  The A|αi| column is the average absolute alpha, the A|αi| /A|ri|  
column is the ratio of the average absolute alpha to the average absolute deviation of the mean 
excess returns from the market index, and the As(αi)2)/A(αi2) column is the ratio of the average 
squared standard error of alpha relative to the average squared alpha.   
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Table 4 Bayesian Pairwise Model Comparison Tests 
 
Panel A: 
Shpmult=1.25 FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM 0.375 0.000 0.005 0.002 0.000 0 0 0 
FF  0.001 0.001 0.004 0.000 0 0 0.000 
Carhart   0.010 0.015 0.002 0.001 0.002 0.003 
FF5    0.867 0.183 0.880 0.027 0.344 
FF5s     0.506 0.003 0.013 0.357 
FF6      0.585 0.031 0.307 
FF6s       0.228 0.366 
DHS        0.929 
Panel B: 
Shpmult=1.5 FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM 0.393 0 0.000 0.000 0 0 0 0 
FF  0 0 0.000 0 0 0 0 
Carhart   0.023 0.023 0.000 0 0.001 0.000 
FF5    0.826 0.024 0.086 0.008 0.024 
FF5s     0.168 0 0.006 0.045 
FF6      0.123 0.077 0.150 
FF6s       0.908 0.726 
DHS        0.685 
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Panel C: 
Shpmult=2 FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM 0.485 0 0 0 0 0 0 0 
FF  0 0 0 0 0 0 0 
Carhart   0.058 0.040 0.000 0 0.000 0 
FF5    0.763 0.002 0.000 0.001 0.000 
FF5s     0.024 0 0.001 0.001 
FF6      0.005 0.184 0.055 
FF6s       0.998 0.959 
DHS        0.209 
Panel D: 
Shpmult=3 FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM 0.655 0 0 0 0 0 0 0 
FF  0 0 0 0 0 0 0 
Carhart   0.135 0.074 0 0 0.000 0 
FF5    0.696 0.000 0 0.000 0 
FF5s     0.003 0 0.000 0.000 
FF6      0.000 0.259 0.022 
FF6s       0.999 0.995 
DHS        0.058 
 
The table reports the posterior probabilities of the models in the rows from the  Bayesian pairwise model comparison tests of nine linear factor 
models between July 1983 and December 2016.  The posterior probabilities of the models in the columns are given by one minus the posterior 
probabilities in the rows.  The prior maximum Sharpe performance (Shpmult) is set equal to multiples of 1.25 (panel A), 1.5 (panel B), 2 (panel 
C), and 3 (panel D) the Sharpe performance of the market index. 
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Table 5 Bayesian Multiple Model Comparison Tests 
 
Shpmult 1.25 1.5 2 3 
CAPM 0.189 0.014 0.000 0 
FF 0 0 0 0 
Carhart 0 0 0 0 
FF5 0.000 0.000 0 0 
FF5s 0 0 0 0 
FF6 0 0 0 0 
FF6s 0 0 0.000 0.010 
DHS 0.809 0.985 0.999 0.989 
AFIM 0 0 0 0.000 
 
The table reports the posterior probabilities of each model from the Bayesian multiple model 
comparison tests of nine linear factor models between July 1983 and December 2016.  The 
prior maximum Sharpe performance (Shpmult) is set equal to multiples of 1.25, 1.5, 2, and 3 
the Sharpe performance of the market index. 
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Table 6 Model Comparison Tests using the Squared Sharpe Performance 
 
Panel A: 
ShpDiff FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM -0.006 -0.098 -0.077 -0.087 -0.144 -0.236 -0.108 -0.174 
FF  -0.091 -0.070 -0.080 -0.137 -0.229 -0.101 -0.167 
Carhart   0.020 0.011 -0.046 -0.138 -0.010 -0.076 
FF5    -0.009 -0.067 -0.159 -0.031 -0.097 
FF5s     -0.057 -0.149 -0.021 -0.087 
FF6      -0.092 0.035 -0.029 
FF6s       0.128 0.062 
DHS        -0.065 
Panel B: 
p values FF Carhart FF5 FF5s FF6 FF6s DHS AFIM 
CAPM 0.100 0 0 0 0 0 0 0 
FF  0 0 0.008 0 0 0.007 0 
Carhart   0.602 0.802 0 0.000 0.815 0.003 
FF5    0.666 0 0.001 0.474 0.001 
FF5s     0.137 0 0.649 0.020 
FF6      0.003 0.453 0.042 
FF6s       0.035 0.080 
DHS        0.173 
Panel C: 
Multiple LR θ 2K pnon-nested r  pnested    
CAPM  0.008       
FF 22.111 0.015 0 3 0    
Carhart 14.717 0.106 0.000 4 0    
FF5 11.896 0.085 0.001 4 0    
FF5s 5.346 0.095 0.028 3 0    
FF6 13.807 0.152 0.000 3     
FF6s 0 0.245 0.677 3     
DHS 4.407 0.116 0.031 3     
AFIM 3.060 0.182 0.133 3     
 
The table reports the classical model comparison tests for nine linear factor models between 
July 1983 and December 2016.  Panels A and B report the pairwise model comparison tests.  
Panel A includes the difference in the bias-adjusted maximum squared Sharpe performance 
between every pair of models and panel B includes the corresponding p values of the equality 
of the squared Sharpe performance of the two models.  Panel C reports the multiple model 
comparison tests.  LR is the Likelihood ratio test of Wolak(1987,1989).  The θ2K column is the 
bias-adjusted maximum squared Sharpe performance.  The pnon-nested column is the p value for 
the LR test of the non-nested multiple model comparison tests, and r is the number of 
alternative non-nested models.  The pnested column is the p value for the nested model 
comparison tests.   
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